Amanote Research
Register
Sign In
Monitoring Effects of Oral Anticoagulants During Treatment With Heparin.
BMJ
doi 10.1136/bmj.288.6412.191
Full Text
Open PDF
Abstract
Available in
full text
Date
January 21, 1984
Authors
P Thomas
A Fennerty
G Backhouse
D P Bentley
I A Campbell
P A Routledge
Publisher
BMJ
Related search
The Treatment of Venous Thromboembolism With New Oral Anticoagulants
Italian Journal of Medicine
Medicine
New Oral Anticoagulants in the Treatment of Pulmonary Embolism: Efficacy, Bleeding Risk, and Monitoring
Thrombosis
Cardiovascular Medicine
Hematology
Cardiology
Reversal of Direct Oral Anticoagulants in Hemophilia Treatment
Memo - Magazine of European Medical Oncology
Oncology
Hematology
Switch From Oral Anticoagulants to Parenteral Heparin in SARS-CoV-2 Hospitalized Patients
Internal and Emergency Medicine
Internal Medicine
Emergency Medicine
A Comparison of Low-Molecular-Weight Heparin and Oral Anticoagulants in the Long-Term Treatment of Acute Deep Venous Thrombosis
Turkish Journal of Thoracic and Cardiovascular Surgery
Respiratory Medicine
Pulmonary
Cardiovascular Medicine
Surgery
Cardiology
Development of Treatment of Cancer-Associated Venous Thromboembolism With Direct Oral Anticoagulants
The Japanese Journal of Phlebology
Pcv138 - Treatment Patterns of Patients With Venous Thromboembolism Treated With Oral Anticoagulants in England
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness of Oral Anticoagulants for Treatment of Atrial Fibrillation
Circulation. Cardiovascular quality and outcomes
Medicine
Cardiovascular Medicine
Cardiology
Role of Novel Oral Anticoagulants in the Treatment of Antiphospholipid Syndrome
Hospital Pharmacy
Pharmacology
Pharmacy